Anzeige
Mehr »
Sonntag, 08.02.2026 - Börsentäglich über 12.000 News
Der Shakeout: Silber hat genau das getan, was echte Bullenmärkte immer tun - es hat die Touristen abgeschüttelt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PZ3E | ISIN: US18507C1036 | Ticker-Symbol:
NASDAQ
06.02.26 | 21:59
13,460 US-Dollar
+7,08 % +0,890
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
CLEARPOINT NEURO INC Chart 1 Jahr
5-Tage-Chart
CLEARPOINT NEURO INC 5-Tage-Chart

Aktuelle News zur CLEARPOINT NEURO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
27.01.CLPT Gets EU MDR Certification for ClearPoint Navigation Software2
23.01.ClearPoint Neuro Gets EU Green Light For Updated Brain Surgery Software3
CLEARPOINT NEURO Aktie jetzt für 0€ handeln
22.01.ClearPoint Neuro receives EU MDR certification for navigation software2
22.01.ClearPoint Neuro erhält EU-MDR-Zertifizierung für Navigationssoftware-
22.01.ClearPoint Neuro, Inc.: ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe294SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation...
► Artikel lesen
12.01.ClearPoint Neuro reports 20% sales growth in Q4 20253
12.01.ClearPoint Neuro announces preliminary unaudited fourth quarter and full year 2025 revenue1
12.01.ClearPoint Neuro, Inc.: ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue275The Company Achieved 20% Comparable Sales Growth in the Fourth Quarter of 2025 at $10.4 Million SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 12, 2026 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the...
► Artikel lesen
12.01.ClearPoint Neuro, Inc. - 8-K, Current Report1
05.01.ClearPoint Neuro schließt Zustimmungsvereinbarung zur Restrukturierung von IRRAS AB-
05.01.ClearPoint Neuro, Inc. - 8-K, Current Report-
05.12.25Here's What Boosted ClearPoint Neuro (CLPT) in Q31
20.11.25ClearPoint Neuro completes acquisition of IRRAS Holdings1
20.11.25ClearPoint Neuro, Inc.: ClearPoint Neuro Completes Acquisition of IRRAS682Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery Innovation SOLANA BEACH, CALIFORNIA / ACCESS Newswire...
► Artikel lesen
20.11.25ClearPoint Neuro, Inc. - 8-K, Current Report-
06.11.25ClearPoint Neuro to acquire IRRAS Holdings in neurocritical care expansion3
06.11.25ClearPoint Neuro, Inc.: ClearPoint Neuro Reports Third Quarter 2025 Results447Site Readiness Continues for Specialized Treatment Centers Envisioned to Support a Growing Number of Cell and Gene Therapy Trial Patients and Later Commercialization SOLANA BEACH, CA / ACCESS Newswire...
► Artikel lesen
06.11.25ClearPoint Neuro, Inc.: ClearPoint Neuro Announces Agreement to Acquire IRRAS446Acquisition Will Further Expand the Potential of ClearPoint Neuro's Drug Delivery Portfolio While Immediately Adding New Indications and Commercial Scale Across a $0.5 Billion Market for the Treatment...
► Artikel lesen
06.11.25ClearPoint Neuro, Inc. - 10-Q, Quarterly Report-
06.11.25ClearPoint Neuro, Inc. - 8-K, Current Report1
Weiter >>
51 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1